Companies / Camp4 Therapeutics Corp

Camp4 Therapeutics Corp

Nasdaq: CAMPCIK 1736730WATERTOWN, MA

Financials · FY2025

Revenue$3.50M
Net income$-80.40M
Total debt—
Cash$86.40M
Diluted EPS$-2.65
Shares outstanding51.9M

Ownership

51.9M shares outstanding · as of May 6, 2026
9.5%10%+ / strategic
Ownership
10%+ / strategic9.47%4,918,243
Institutions67.62%35,112,815
Public float22.91%11,894,742

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Holtzman Steven HDirector
——
MacLean Michael FDirector
——
Williams Douglas EDirector
——

Institutional holders 43

View all →
HolderValue% of shares
5AM Venture Management, LLC$35.98M11.30%
Fmr LLC$30.15M9.47%
Janus Henderson Group PLC$27.88M12.15%
Vivo Capital, LLC$26.03M8.18%
Enavate Sciences GP, LLC$18.61M5.85%
a16z Capital Management, L.L.C.$13.03M4.09%
Trails Edge Capital Partners, LP$12.16M3.82%
Balyasny Asset Management L.P.$11.61M5.07%
Vanguard Group Inc$10.26M3.22%
Adage Capital Partners Gp, L.L.C.$8.65M3.78%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 1, 2026MacLean Michael F
Director
GrantStock Option (Right to Buy)—+56K
56,000
0.11% of shares
low
Jun 10, 2026Holtzman Steven H
Director
GrantStock Option (Right to Buy)—+28K
28,000
0.05% of shares
low
Jun 10, 2026Williams Douglas E
Director
GrantStock Option (Right to Buy)—+28K
28,000
0.05% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Janus Henderson Group PLCPassive13G———
Fmr LLCPassive13G/A—4,918,243—
Vivo Opportunity Fund Holdings, L.P.Passive13G/A———
Balyasny Asset Management L.P.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CAMP——13463J101—